Woman and Man
- | Country :
- Ukraine
- Lebanon
- Russian Federation
- | organs : -
- | Specialty : -
Extract
Primary Objective: -To demonstrate the efficacy of a fixed combination of glimepiride + metformin in terms of HbA1c reduction, during 24-week treatment period in patients with inadequately controlled type 2 diabetes mellitus. Secondary Objective: To assess the effects of the fixed combination of glimepiride and metformin at week 24 on: - Percentage of patients reaching HbA1c <7% - Percentage of patients reaching HbA1c <6.5%. - Fasting Plasma Glucose (FPG) - Safety and tolerability
Inclusion criteria
- Type 2 diabetes mellitus